Autoimmune Diseases Respond to Teclistamab but With Risks
Teclistamab may have potential for clinical responses in patients with refractory autoimmune diseases; however, cytokine release syndrome and infections occur frequently. Medscape Medical News
Read the full articleYou might also wanna read
Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Refractory Autoimmune Encephalitis and Autoimmune Cerebellitis
Conditions : Autoimmune Encephalitis (AE); Autoimmune Cerebellitis Interventions : Drug: Blinatumomab Sponsors : Beijing Tiantan Hospital No
META 10-19 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia
Conditions : Autoimmune Hemolytic Anemia (AIHA) Interventions : Biological: Metabolically Armed Autologous CD19 CAR T-Cell therapy Sponsors
Científicos consiguen que dos personas estén más de 15 años libres de una grave enfermedad autoinmune que afecta a la médula espinal
Las células madre de ldonante logran ‘reiniciar’ el sistema inmunitario del paciente y reconstruir las defensas del organismo desde cero
Resetting autoimmune disease with CAR cell therapies
Explore the potential of CAR T cells in autoimmune diseases: a novel way to target B cells, reset immunity, and meet clinical gaps! PMID:421
A revolutionary cancer treatment could transform autoimmune disease
Researchers are testing CAR T cell therapy as a way to reset the immune system in lupus, Graves’ disease and other conditions where the body
OHSU logra un gran avance en la ciencia médica con las terapias celulares
Los pacientes se benefician de la terapia CAR-T para tratar enfermedades neurodegenerativas, cáncer, lupus y otras afecciones autoinmunes.
Comments
Sign in to join the conversation.
No comments yet. Be the first.